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ABSTRACT 
Apathy is a prominent symptom of Amyotrophic lateral sclerosis (ALS), but 
measurement is confounded by physical disability. Furthermore it has been 
traditionally measured as a unidimensional symptom despite research 
demonstrating a multifaceted construct. The new Dimensional Apathy Scale 
(DAS) has been specifically designed for patients with motor disability to 
measure three neurologically based subtypes of apathy; Executive, Emotional 
and Initiation. We aimed to explore this behavioural symptom by examining the 
substructure of apathy in ALS and to determine the reliability and validity of the 
DAS in patients and their carers.  
Method: Patients and carers were recruited through the national Scottish Motor 
Neurone Disease Register and were asked to complete the DAS, the standardised 
Apathy Evaluation Scale, and the Geriatric Depression Scale- Short form. 83 ALS 
patients, 75 carers and 83 sex-age-education matched controls participated. 
Results: When compared to healthy controls, patients showed a significant 
increase in apathy on the Initiation subscale, and were significantly less 
apathetic on the Emotional subscale. Scores on the DAS patient and carer 
versions did not significantly differ. Internal consistency reliability, convergent 
and discriminant validity were found to be good for the DAS subscales. There 
was no association between the DAS and functional disability using the ALS 
Functional Rating Scale. 
Conclusion: Apathy in ALS is characterised by a specific profile of increased 
Initiation apathy and reduced Emotional apathy. The DAS is a reliable and valid 
measure for the assessment of multidimensional apathy in ALS. 
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INTRODUCTION 
Apathy is defined by decreased motivation towards goal directed behaviours,[1] 
and occurs as a symptom of a variety of different psychiatric and 
neurodegenerative diseases,[2, 3]. Studies have shown that apathy occurs in 
30% to 60% of ALS patients and is the most prominent behavioural symptom of 
the disease,[4-7]. This behavioural change in ALS has most commonly been 
detected by the Frontal Systems Behavior Scale (FrSBe) apathy subscale,[8]. 
However, this tool is not specifically designed to assess patient populations with 
physical disability and may exaggerate behavioural symptoms as responses to 
some items are reliant on effective motor functions,[9]. Other tools which have 
been used to detect behavioural change in ALS are the Cambridge Behaviour 
Inventory- Revised,[10], the ALS- Frontotemporal Dementia- Questionnaire,[11] 
and, finally, the Motor Neurone Disease Behavioural Instrument,[12]. These 
measure apathy as a part of just one of many behavioural or psychiatric 
disturbances and lack a detailed analysis of symptoms. 
 
Marin originally defined apathy as a multidimensional concept that is composed 
of factors relating to cognitive, behavioural and emotional domains,[13, 14]. 
Although no previous scales have been comprehensively designed to directly 
measure the subdomains of apathy, factorial analysis of current scales has 
revealed a sub structure similar to that of Marin’s original conceptualisation in 
Parkinson’s disease,[15], observing a traditional triadic substructure. 
Additionally, in a comparison of Alzheimer’s disease and Frontotemporal 
dementia, apathy was found to have differing profile characteristics,[16]. 
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Specifically, the Neuropsychiatric Inventory – apathy subscale items showed that 
behavioural variant Frontotemporal dementia patients were reported as more 
frequently showing lack of initiation, decreased emotional output and 
diminished interest towards friends or family, when compared to Alzheimer’s 
disease patients. However, no such research has been undertaken in ALS as yet. 
 
Traditional instruments measure apathy as a unidimensional symptom despite 
clear evidence of a multidimensional substructure. The new Dimensional Apathy 
Scale (DAS),[17] was designed in a cohort of healthy adults for use in 
neurodegenerative disease patient populations with motor symptoms. The DAS 
was specifically designed to measure three neurobehavioral apathy 
subtypes,[18, 19] through theory based analysis and selection of items. It 
assesses apathetic impairments associated with planning, attention or 
organization (Executive), emotion integration (Emotional) and self-generation of 
behaviours or cognition (Initiation). The DAS has been shown to have good 
internal consistency reliability, with subscales having a moderate relationship to 
depression and is the only method that comprehensively measures apathy 
subtypes. 
 
Apathy and depression have been reported to have a variable relationship, with 
some studies describing them as distinct factors and others reporting an 
association.[20, 21]. Lack of interest, insight and reduced energy have been 
suggested as overlapping characteristics of apathy and depression, with 
dysphoria, suicidal ideation and helplessness being depression specific and 
indifference, diminished initiation and poor persistence being apathy 
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specific,[22-25]. Documenting the relationship between apathy and depression 
in neurodegenerative disease remains important as they may be differentially 
affected or overlapping symptoms misattributed.  
 
The aim of this study was to determine why apathy is a particularly prominent 
feature of ALS through an exploration of the substructure of this behavioural 
symptom. In addition we aimed to determine the psychometric properties of the 
DAS, namely the validity as assessed against a standardised measure of apathy 
and its association with depression and disease related disability. 
  
METHOD 
Procedure and Participants 
El Escorial criteria diagnosed ALS patients and their carers were recruited from 
the national Scottish Motor Neurone Disease Register. Patients were recruited 
via postal survey. Patients with Primary lateral sclerosis or Progressive muscular 
atrophy were not included in the study. Carers were recruited via the patients 
through a chain-referral sampling method. Patients were anonymously pre-
screened for severe disability as a result of disease progression that would 
hinder completion of the survey, pre-existing dementia, severe diabetes, 
epilepsy, alcohol/substance- related disorders, severe head injury (that required 
intensive care setting hospitalisation), traumatic brain injury (inclusive of 
subarachnoid haemorrhage) and any other significant medical illness (such as 
stroke).  
 
 
 
 6 
Of 190 ALS patients who were contacted, 46.8% patients and 44.2% carers 
returned the postal survey. Of the participants who returned the survey, 3.5% of 
patients and 5.9% of carers returned incomplete questionnaires and were 
subsequently excluded. A further 3.5% of carers did not have a matched patient 
completed form and were also excluded. This resulted in 83 ALS patients and 75 
carers being included in the study. 
 
400 healthy control participants completed the study. They were recruited via 
web-based survey and were mostly from the University of Edinburgh Psychology 
Departmental Volunteer Panel. Before recruitment, they were additionally pre-
screened for any serious physical or mental health issues. 83 healthy controls 
were subsampled from this pool to match the patient group for sex distribution, 
age and years of education. 
 
Ethical approval was obtained from the National Health Service (NHS) South 
East Scotland Research Ethics Committee 02 and the School Philosophy, 
Psychology and Language Sciences (PPLS) Ethical Committee. 
 
Apathy 
The DAS,[17] is multidimensional scale composed of 24 items constituting 3 
subscales assessing Executive, Emotive and Initiation apathy. Items were scored 
using a 4-point Likert scale based on the frequency of occurrence in the last 
month. The minimum score for each subscale is 0 (least apathy) and the 
maximum 24 (most apathy), with a total score of 72. It was shown to have good 
internal consistency reliability and to have a weak to moderate relationship with 
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depression. A self version has been previously reported by the authors and a 
carer version was adapted specifically for this study1. Normative data was 
subsequently used to suggest abnormality level cut-offs for each subscale based 
on ≥2 SD above the mean (see Table 1). 
 
Table 1. Normative Data on DAS (N=83) 
 Mean (SD) Range Abnormality cut-off  
DAS Executive subscale 5.9 (4.2) 0–17 14 
DAS Emotional subscale 8.8 (2.9) 3–19 15 
DAS Initiation subscale 9.5 (3.5) 1–17 16 
DAS Total  24.1 (7.3) 8-42 39 
DAS=Dimensional Apathy Scale, the maximum for each subscale is 24 and the total is 72 
 
The Apathy Evaluation Scale (AES),[14] is composed of 18 items and is scored on 
a 4 point Likert scale based on frequency of occurrence in the last month. It 
produces one composite score, where the minimum score is 18 (least apathy) 
and maximum score of 72 (most apathy). The recommended cut-offs for the self 
version is based on 2 standard deviations above the mean,[14]. For our control 
sample this was 39, which is consistent with the original study. The carer version 
cut-off was defined as 40. The AES is a well-established method of detecting 
apathy, and has been shown to be both valid and reliable,[3, 25]. Both a carer 
and patient versions were available.  
 
Depression 
                                                        
1 See Supplementary material 
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Geriatric Depression Scale-Short form (GDS-15),[26, 27] is an abridged version 
of the Geriatric Depression Scale. It is composed of 15 items, with statements 
graded on a dichotomous, yes-no scale within the previous week. The minimum 
score is 0 (not depressed) with the maximum being 15 (most depressed). 
Recommended cut-offs for the patient self rated version are disputed but highest 
consensus in the literature is a cut-off of >6 for presence of depressive 
symptoms,[28]. Both a patient and carer version were used. 
 
Disease Related Disability  
The ALS Functional Rating Scale-Revised (ALSFRS-R),[29] is a 12 domain global 
functioning and disability measure specifically designed for assessment of ALS 
patients. Each domain scored on a 5 point scale with the total score ranges from 
0 (maximum disability) and 48 (normal motor function). 
 
Statistical Analysis 
R and SPSS statistics 19.0 was used to analyse the results. Independent t-tests 
and Chi-square tests were used to compare demographics, symptom frequency 
and clinical variables between ALS patients, and controls, DAS Subscale impaired 
patients and unimpaired patients. Internal consistency reliability was assessed 
using Cronbach’s Standardized alpha. Validity was examined using correlational 
analysis (Holm corrected Pearson’s r). A 2 x 3 Mixed design Analysis of variance 
(ANOVA) was used for comparison of Group (Patients vs Carers/Controls) and 
DAS subscale (Emotional vs Executive vs Initiation). Post hoc Independent t-tests 
were used for subscale and factor comparison. 
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RESULTS 
Table 2. Demographic and descriptive data for ALS patients (N=83), their 
carers (N=75) and controls (N=83) 
 ALS Patient ALS Carer Control Patient vs 
Control p-
value 
DAS Total Score (mean, 
SD) 
25.7 (10.6) 27.3 (12.8) 24.1 (7.3) n.s. 
DAS Total (Apathy/No 
Apathy) 
12/71 14/61 2/81 <.01 
AES Score (mean, SD) 30.9 (8.6) 32.8 (10.9) 28.9 (5.0) n.s. 
AES (Apathy/No Apathy) 20/63 18/57 1/82 <.001 
GDS-15 Score (mean, SD) 5.9 (4.2) 6.7 (4.7) 2.5 (2.8) <.001 
Age (mean, SD) 64.6 (10.5)  63.7 (13.0) n.s. 
Years of Education (mean, 
SD) 
13.5 (3.4)  14.4 (2.7) n.s. 
ALSFRS-R Score (mean, 
SD) † 
37.7 (6.2)    
Age of onset (mean, SD) 
years† 
59.6 (11.0)    
Disease duration (Median, 
IQR) months†† 
66.5 (71)    
ALS=Amyotrophic lateral sclerosis; SD=standard deviation; DAS=Dimensional Apathy 
Scale; AES=Apathy Evaluation Scale; GDS-15=Geriatric depression scale- Short form;  
ALSFRS-R=ALS Functional Rating Scale-Revised; n.s.=not significant; IQR=Interquartile 
range 
† N=32 
†† N=62 
 
Background Information 
There was no significant difference between patients and controls on age and 
years of education (see Table 2). Sex distributions were matched, with 57 males 
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and 26 female participants in both samples. The most common carer relationship 
to the ALS patient was a spouse.   
 
Apathy (AES) and Depression 
The results of the AES revealed that the total score was not found to significantly 
differ between patients and controls, however the number of individuals who fell 
above the suggested cut-off for abnormality did, with significantly increased 
levels of abnormal apathy in the patient group (see Table 2).  
 
In this sample, according to the AES, 24% of patients self rated and 24% of 
carers rated patients as apathetic. Depression rates were higher, with patient-
rated depression at 39% and carer-rated depression at 44%. Additionally, 
patient reported depression scores were found to be significantly different when 
compared to controls and just under borderline diagnosis level (see Table 2). 
Furthermore the AES was found to be positively correlated with GDS-15 in 
patients (r(73) = .65, p < .001) and carers (r(81) = .67, p < .001). 
 
Patient (self-rated) and Carer-rated comparison on the DAS 
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The comparison between Group (Self vs Carer) and DAS subscales is presented 
in Figure 1. There was no significant interaction between Group and the DAS 
Subscales with carer’s ratings being only, on average 0.7, points higher than 
patient self ratings. However, there was a significant main effect relating to DAS 
subscales  (F(2,296) = 160.30, p < .001). Post hoc independent t-tests within 
groups showed that in patients the DAS Executive subscale differed significantly 
from Emotional subscale (t(164) = 3.53, p < .01) and the Initiation subscales 
(t(164) = 9.11, p < .001), in addition there was a significant difference between 
Emotional and Initiation subscales  (t(164) = 7.19, p < .001). In carers, a similar 
relationship between subscales was found where the DAS Executive and 
Emotional subscales differed significantly (t(148) = 3.42, p < .01), along with 
Executive and Initiation subscales (t(148) = 7.93, p < .001) and Emotional and 
Initiation subscales (t(148) = 5.45, p < .001). There was no significant difference 
on the DAS total score between patient and carer ratings. 
 
 
 
 
 12 
 
 
 
 
 
 
 
 
 
Patient (self-rated) and Healthy Control comparison on the DAS 
 
 
A comparison of group (Self vs Control) and DAS Subscale, showed a significant 
main effect for DAS subscales (F(2,328) = 107.16, p < .001) indicating 
dissociations between subscales (see Figure 2). In addition, a significant 
interaction was also found between Group and DAS subscales, reflecting 
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differential performance between patients and controls on the different 
subscales (F(2,328) = 18.56, p < .001).  
 
Further post hoc t-tests showed that Initiation was the only subscale in which 
patients were significantly more apathetic than controls (t(164) = 4.52, p < .001).  
Additionally, on the emotional apathy subscale, patients scored significantly 
lower when compared to control participants (t(164) = 2.15, p < .05). The DAS 
total score did not significantly differ between patients and controls. 
 
Psychometrics 
The overall DAS Cronbach’s Standardized alpha values were 0.86 for the self-
version and 0.90 for carer-version, which can be interpreted as good and 
excellent [3], respectively. There were good internal consistencies for both the 
Executive (self = 0.86, carer = 0.88) and Initiation (self = 0.83, carer = 0.86) 
subscales, with the poorest being for self DAS Emotional subscale at 0.43. 
However, the carer Emotional subscale showed a higher internal consistency at 
0.65. 
 
Table 3. Patient (self rated) and carer rated DAS subscale correlations 
compared to standardised, self-report apathy (AES) and depression 
(GDS15) measures  
Self (N=83) AES GDS-15 
DAS Executive subscale 0.76*** 0.61*** 
DAS Emotional subscale 0.21 0.20 
DAS Initiation subscale 0.79*** 0.61*** 
DAS Total 0.80*** 0.67*** 
Carer (N=75) AES GDS-15 
DAS Executive subscale 0.82*** 0.64*** 
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DAS Emotional subscale 0.44*** 0.24* 
DAS Initiation subscale 0.79*** 0.65*** 
DAS Total 0.85*** 0.64*** 
DAS=Dimensional Apathy Scale; AES=Apathy Evaluation Scale; GDS-15=Geriatric 
Depression Scale- Short Form           p<.001***, p<.05* 
 
The DAS Subscales positively correlated with the AES, with moderate 
correlations with the Emotional subscale and strong correlations with the 
Executive and Initiation subscales (see Table 3). Similarly the carer DAS 
subscales were more positively correlated with the AES compared to the GDS-15. 
 
Disease related disability 
A total of 32 patient’s and, of those, 27 carer’s ALSFRS-R scores were acquired. 
The ALSFRS-R did not significantly correlate with the self DAS Executive 
subscale, Emotional subscale, Initiation subscale and the total score. When 
compared to the carer version of the DAS, the ALSFRS-R was also not 
significantly correlated with any of the subscales and the total score.  
 
Diagnostic cut-off for the DAS 
Using the abnormality level cut-offs in Table 1, 28% of ALS patients were 
impaired on at least one apathy subscale, of which 61% were impaired on the 
Initiation subscale only and 39% were impaired on Initiation and one other 
subscale (30% Executive and 9% Emotional). In carers, 43% were impaired in at 
least one subscale, where 56% were impaired on the Initiation subscale only, 
10% on the Executive subscale only and 6% on the Emotional subscale only. A 
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further 16% displayed Initiation and Executive apathy with 6% showing 
Initiation and Emotional apathy. A total of 6% showed apathy on all 3 subscales. 
 
Table 4. Comparison of patients (carer-rated) impaired on ≥1 DAS 
Subscales (N=25) to patients unimpaired on all subscales (N=34) 
 ≥1 Subscale 
Impairment 
Unimpaired p-value 
ALSFRS-R (Mean, SD) 38.8 (4.2) † 36.6 (8.8) †† n.s. 
Disease duration (Median, IQR) 45 (53) 98 (74) <.05 
Age of Onset (Mean, SD) 57.2 (11.4) 60.6 (10.6) n.s. 
Site of Onset (%)    
 Bulbar (N=15) 26.7% 73.3%  
 Lower Limb (N=21) 47.6% 52.4%  
 Upper Limb (N=19) 47.4% 52.6%  
 Mixed (N=4) 50% 50%  
ALSFRS-R=ALS Functional Rating Scale- Revised; SD=standard deviation; n.s.=not 
significant; IQR=Interquartile range 
† N=10 
†† N=11 
 
Table 4. is a comparison clinical variables in apathetic and non-apathetic 
patients as defined by impairment on at least one DAS subscale as rated by the 
carer. Of the 75 carer rated DAS scores, 16 patient’s clinical variables were 
unavailable, resulting in a total of 59 patient’s clinical variables being used. 
There was a significant difference between the two groups on disease duration, 
wherein ≥1 Subscale Impairment patients had the disease for a shorter time at 
assessment. The proportion of impaired and unimpaired patients with lower 
limb, upper limb and mixed onset was relatively equal, although those with 
bulbar onset were more likely to be unimpaired than impaired. However, 
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frequency distributions did not differ using Chi-square statistics (which excluded 
the mixed onset in the analysis). 
 
 
 
Figure 3 shows a further subdivision of impairment (impaired on all three 
subscales, impaired on two subscale and impaired on one subscale) based on site 
of onset. All bulbar onset patients who were impaired on the DAS showed 
impairment on one subscale, while those with lower limb onset and upper limb 
onset were impaired on 2 or more subscales. The only 2 instances of global 
impairment were in the upper limb onset group. The most common impairment 
on one subscale across all groups was on the Initiation subscale. 
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DISCUSSION 
The DAS was shown to be sensitive to apathy in ALS, where 28% of patients and 
43% of carers in our sample showed abnormal levels of apathy on at least one 
subscale. The prevalence of apathy reported here is slightly lower than previous 
studies, where apathy was reported between 30-60% of the patients sampled [4-
7]. However previous studies have utilised measures, which have not been 
designed for physical disability and where symptoms of apathy may be 
exaggerated by motor dysfunction. The more conservative estimate reported 
here might be therefore a more accurate reflection given that the DAS was 
designed to measure apathy independent of physical disability.  
 
The most prevalent DAS subscale impairment was in Initiation with ALS patients 
showing significantly increased Initiation apathy compared to controls. Initiation 
apathy consists of a lack of self generated behaviour and cognition,[22]. Such 
processes are also dependent on intact executive functions, which are known to 
be affected in ALS,[30]. 
 
Stuss proposed a model of executive functions that includes the concept of 
energization, defined as diminished initiation and sustainment of responses to 
tasks,[31, 32] and which clearly has overlap with Initiation apathy. Energization 
deficits are often observed as decreased output during verbal fluency tasks, 
increased errors and slow response time for Stroop tasks. This verbal fluency 
deficit is a characteristic feature of the cognitive profile in ALS,[30] and has been 
found to correlate with apathy as measured by the FrSBe,[4]. Further research 
using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS),[33] found a 
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high prevalence of the fluency deficit in ALS patients and, additionally, reported 
apathy as the most prevalent behavioural impairment although the behaviour 
screen contains just one item on apathy. 
 
Initiation apathy is akin to one of Levy and Dubois apathy subtypes- Auto 
Activation,[18]. This type of apathy has been related to lesions in the medial 
prefrontal region, anterior cingulate cortex and caudate nucleus. Brain imaging 
studies have found abnormalities in ALS patients in the anterior cingulate cortex 
to be related to apathy,[34] and the caudate nucleus has also been shown to be 
affected in ALS, and it was posited that this may be involved with the mediation 
of motivation,[35]. Similarly verbal fluency deficits (the key feature of the 
energization deficit) has been related to dysfunction of similar prefrontal 
regions,[36, 37]. 
 
It is of note that the Executive subscale showed no difference between patients 
and controls. This subscale assesses apathy as a result of poor planning, 
organisation and attention. At first glance this appears inconsistent with 
research demonstrating executive dysfunction is a common feature in non-
demented ALS patients as revealed through neuropsychological evaluation. 
However there are very few reports of this deficit manifesting behaviourally or 
having an impact on daily functioning in non-demented ALS patients,[38, 39]. 
Current research within ALS distinguishes between the types of executive 
functions, which are impaired with distinct neural substrates,[37]. The 
distinction between Initiation and Executive apathy is further supported by Levy 
and Dubois,[18, 19], and our own data driven approach, which also separated 
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these two factors,[17] in healthy controls. The findings here demonstrate that 
the processes of initiation of thought and action appear to be the crucial element, 
which underlie the behavioural manifestation of apathy in ALS.  
 
The finding of lower Emotional apathy in ALS, when compared to controls, may 
be related to dysfunction in emotional processing, theory of mind and social 
cognition in ALS which has been recently documented,[9]. A deficit in social 
cognition has been associated with apathy, although cognitive impairment was 
associated with an increased level of apathy,[7]. Future studies may demonstrate 
whether this social cognitive impairment is related to increased Initiation apathy 
specifically. Other factors must be considered in relation to this lack of emotional 
indifference in ALS patients. These may include increased sensitivity to emotion 
associated with reaction and impact of having a terminal disease. However it 
should be noted that there was only a weak correlation between emotional 
apathy and depression, which was in a positive direction, i.e. the more apathetic 
the more depressive symptoms. Conversely the patients with lower emotional 
apathy tended towards fewer depressive symptoms. However ALS patients do 
show a higher incidence of emotional lability, which is involuntary occurrence of 
positive (laughing) and negative (crying) emotions,[40], which may be regarded 
as the antithesis of Emotional apathy. Emotional lability was not recorded here 
and it may serve as an underlying factor in the reduced emotional apathy in ALS 
patients. 
 
There were some differences in clinical variables between patients with apathy 
and those without when broken down by the impairment on the DAS. Patients 
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with apathy as defined by impairment on one or more subscales had the disease 
for a shorter number of months when compared to unimpaired patients. This is 
consistent with the finding that apathy is the most common behavioural change 
associated with the onset of disease, as measured by the FrSBe,[4]. It would also 
be of interest to explore how apathy develops through progression of the 
disease. Cognitive impairment has been shown to be a negative prognostic 
factor,[41] and the current research poses the question of whether this is also 
true of patients with apathy. Prospective studies may also determine the course 
of this symptom and whether apathy characterises a distinct subgroup of 
patients. 
 
Further break down of impairment showed that all patients irrespective of site of 
onset were most commonly impaired on one subscale, that being Initiation. This 
provides further evidence that the Initiation deficit is that which defines apathy 
in ALS. It is also of interest that the patients with bulbar onset did not show a 
greater vulnerability to apathy, and therefore does not support previous 
associations of cognitive and behaviour change and bulbar symptomology,[42].  
Given that functional disability data was only available on a subgroup of patients, 
although no correlations emerged here, the relationship between this 
behavioural symptom and physical dysfunction and progression should be 
further explored. 
 
The DAS was found to be a psychometrically robust instrument for detecting 
apathy in ALS, with very little difference between patient and carer ratings. 
There was a consistent dissociation between the DAS subscales in patients, 
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carers and also controls, providing evidence for the DAS measuring distinct 
subtypes of apathy. Previous reviews of assessment methods in ALS outlined one 
of the main issues of behavioural measurement is that it is confounded by motor 
dysfunction,[9]. The DAS was specifically designed to account for these motor 
symptoms and the current findings of apathy were independent of functional 
disability supporting its usage in patients with motor symptoms. Furthermore, 
our control samples apathy levels, as measured by the AES, were comparable to 
that of Marin’s in his original validation of the AES (Mean=28.1, Standard 
Deviation=6.4),[14] making our control group no more apathetic than in Marin’s 
original study and therefore suitable for comparison to the patients group. 
 
The internal consistency reliability for the whole DAS was good, with it being 
higher for the carer (0.90) than the self version (0.86). When examining subscale 
internal consistency reliability, we found that the self and carer Executive and 
Initiation subscales were found to be very reliable however, the self DAS 
Emotional subscale was found to be poor. Patients’ self awareness may be 
affecting performance on the self rated questionnaire, and there is some 
evidence of poor insight in ALS patients,[43]. However it is at present unclear 
why this would differentially affect the emotional component and this 
interaction may be an area for future research. The internal consistency for the 
carer Emotional subscale was markedly higher, suggesting that the carer 
assessment might be a more informative method of assessing Emotional apathy.  
 
Our study found that associations with the DAS apathy subscales and the 
standardized apathy measure (AES) were on average more positive and stronger 
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than with the depression measure (GDS-15), resulting in a good convergent and 
discriminant validity of the DAS. When looking specifically at the Emotional 
apathy subscale, the self version was marginally more positively associated with 
the AES than the GDS-15, however the difference was minor. The carer DAS 
Emotional subscale more positively and strongly associated with the AES than 
the GDS-15, showing in a good validity and reliability of this subscale. The 
prevalence of depression in our patient sample was found to be in line with that 
of other studies,[44].  
 
A caveat of all apathy research is volunteerism, where participants who 
participate in studies are likely to be more motivated and less apathetic. Our 
study may, therefore, be underrepresenting the prevalence of apathy in ALS.  
However the response rate of the current research (46.8% patients and 44.2% 
carers) is as good if not better than other MND studies,[6].  
 
To conclude, the DAS is a psychometrically valid and reliable instrument for 
detecting dissociable apathy subtypes, independent of physical disability. Apathy 
in ALS seems to be defined by specific impairments in initiation of cognition and 
behaviour. Additionally, patients seem to exhibit a lack of Emotional apathy. 
These novel findings suggest that apathy in ALS has a specific profile relating to 
initiation and emotion. The relationship between these subtypes and cognitive, 
behavioural and emotional change should be further explored. Furthermore the 
DAS is appropriate to use to determine different apathetic profile impairments in 
other neurodegenerative diseases, in which apathy is most prevalent. Future 
research should look to investigate the neuropsychological correlates associated 
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with different apathetic subscale profiles in addition to quality of life and both 
patient and caregiver burden with the aim of directing care.  
 
ACKGNOWLEDGEMENTS 
This study was funded by the Alzheimer Society Dementia Research Centre, the 
Anne Rowling Regenerative Neurology Clinic and the University of Edinburgh. 
With thanks to the MND Register, hosted by Euan Macdonald Center for MND 
Research and funded by MND Scotland. Thank you to Ms Judith Newton and all 
the clinicians who helped with recruitment. The authors would like to thank all 
the patients and their carers for participating in this research. 
 
COMPETING INTERESTS 
None. 
 
REFERENCES 
1  Marin RS. Apathy: concept, syndrome, neural mechanism and 
treatment. Semin Clin Neuropsychiatry 1996:1;304–14. 
2  Chase TN. Apathy in neuropsychiatric disease: diagnosis, pathophysiology 
and treatment. Neurotox Res 2011:19;266–78. 
3  Radakovic R, Harley C, Starr JM, et al. A systematic review of the validity and 
reliability of apathy scales in neurodegenerative conditions. Int Psychogeriatr 
2015:27;903–23. 
4  Grossman AB, Woolley-Levine S, Bradley WG, et al. Detecting 
neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral 
Scler 2007:8;56–61. 
 
 
 24 
5  Witgert M, Salamone AR, Strutt AM, et al. Frontal‐lobe mediated behavioral 
dysfunction in amyotrophic lateral sclerosis. Eur J Neurol  2010:17;103–10. 
6  Lillo P, Mioshi E, Zoing MC, et al. How common are behavioural changes in 
amyotrophic lateral sclerosis? Amyotroph Lateral Scler 2011:12;45–51. 
7  Girardi A, MacPherson SE, Abrahams S. Deficits in emotional and social 
cognition in amyotrophic lateral sclerosis. Neuropsychology 2011:25;53–65. 
8  Grace J, Malloy P. Frontal Systems Behavior Scale (FrSBe): Professional 
Manual. Lutz, FL, Psychological Assessment Resources, 2001. 
9  Goldstein LH, Abrahams S (2013). Changes in cognition and behaviour in 
amyotrophic lateral sclerosis: nature of impairment and implications for 
assessment. Lancet Neurol 2013:12;368–80. 
10  Wear HJ, Wedderburn CJ, Mioshi E, et al. The Cambridge behavioural 
inventory revised. Dementia & Neuropsychologia 2008:2;102–7. 
11  Raaphorst J, Beeldman E, Schmand B, et al. The ALS-FTD-Q A new screening 
tool for behavioral disturbances in ALS. Neurology 2012:79;1377–83. 
12  Mioshi E, Hsieh S, Caga J, et al. A novel tool to detect behavioural symptoms in 
ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014:15;298–304. 
13  Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin 
Neurosci 1991:3;243–54. 
14  Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the 
Apathy Evaluation Scale. Psychiatry Res 1991:38;143–62. 
15  Kay DB, Kirsch-Darrow L, Zahodne LB, et al. Dimensions of Apathy in 
Parkinson's Disease: Exploratory Factor Analysis of the Apathy Scale. J 
Parkinson's Dis 2012:2;161–6. 
 
 
 25 
16  Quaranta D, Marra C, Rossi C, Gainotti G, Masullo C. Different apathy profile in 
behavioral variant of frontotemporal dementia and Alzheimer's disease: a 
preliminary investigation. Curr Gerontol Geriatr Res 2012:2012;719250. 
17  Radakovic R, Abrahams S. Developing a new apathy measurement scale: 
dimensional apathy scale. Psychiatry Res 2014:219;658–63. 
18  Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-
basal ganglia circuits. Cereb Cortex 2006:16;916–28. 
19  Levy R. Apathy: A pathology of goal-directed behaviour. A new concept of the 
clinic and pathophysiology of apathy. Rev Neurol 2012:168;585–97. 
20  Levy ML, Cummings JL, Fairbanks LA, et al. Apathy is not depression. J 
Neuropsychiatry Clin Neurosci 1998:10;314–9. 
21  van Reekum R, Stuss DT, Ostrander L. Apathy: why care?. J Neuropsychiatry 
Clin Neurosci 2005:17;7–19. 
22  Landes AM, Sperry SD, Strauss ME, et al. Apathy in Alzheimer's disease. J Am 
Geriatr Soc 2001:49;1700–7. 
23  Landes AM, Sperry SD, Strauss ME. Prevalence of apathy, dysphoria, and 
depression in relation to dementia severity in Alzheimer’s disease. J 
Neuropsychiatry Clin Neurosci 2005:17;342–9. 
24  Tagariello P, Girardi P, Amore M. Depression and apathy in dementia: same 
syndrome or different constructs? A critical review. Arch Gerontol Geriatr 
2009:49;246–9. 
25  Clarke DE, Ko JY, Kuhl, EA, et al. Are the available apathy measures reliable 
and valid? A review of the psychometric evidence. J Psychosomatic Res 
2011:70;73–97. 
 
 
 26 
26  Yesavage JA, Sheikh JI. Geriatric Depression Scale (GDS) Recent Evidence and 
Development of a Shorter Violence. Clin Gerontol 1986:5(1-2), 165–73. 
27  Brown LM, Schinka JA. Development and initial validation of a 15-item 
informant version of the Geriatric Depression Scale. Int J Geriatr Psychiatry 
2005:20;911–8. 
28  Wancata J, Alexandrowicz R, Marquart B, et al. The criterion validity of the 
Geriatric Depression Scale: a systematic review. Acta Psychiatr 
Scand 2006:114, 398–410. 
29  Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS 
functional rating scale that incorporates assessments of respiratory 
function. J Neurol Sci 1999:169;13–21. 
30  Abrahams S, Leigh PN, Harvey A, et al. Verbal fluency and executive 
dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 
2000:38;734–47. 
31  Stuss DT, Alexander MP. Is there a dysexecutive syndrome?. Philo Trans R 
Soc B: Biol Sci 2007:362;901–15. 
32  Stuss DT. Functions of the frontal lobes: relation to executive functions. J Int 
Neuropsychol Soc 2011:17;759–65.  
33  Abrahams S, Newton J, Niven E, et al. Screening for cognition and behaviour 
changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 
2014:15;9–14. 
34  Woolley SC, Zhang Y, Schuff N, et al. Neuroanatomical correlates of apathy in 
ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler 2011:12;52–
8. 
 
 
 27 
35  Bede P, Elamin M, Byrne S, et al. Basal ganglia involvement in amyotrophic 
lateral sclerosis. Neurology 2013:81;2107–15. 
36  Abrahams S, Goldstein, LH, Simmons A, et al. Word retrieval in amyotrophic 
lateral sclerosis: a functional magnetic resonance imaging study. Brain 
2004:127;1507–17. 
37  Pettit LD, Bastin ME, Smith C, et al. Executive deficits, not processing speed 
relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral 
sclerosis. Brain 2013:136;3290–304. 
38  Barson FP, Kinsella GJ, Ong B, et al. A neuropsychological investigation of 
dementia in motor neurone disease (MND). J Neurol Sci 2000:180:107–13. 
39  Goldstein LH, Adamson M, Jeffrey L, et al. The psychological impact of MND 
on patients and carers. J Neurol Sci 1998:160(suppl 1);S114–21. 
40  Palmieri A, Abrahams S, Sorarù G, et al. Emotional Lability in MND: 
Relationship to cognition and psychopathology and impact on caregivers. J 
Neurol Sci 2009:278;16–20. 
41  Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline 
in ALS: A population-based longitudinal study. Neurology 2013:80;1590–7. 
42  Abrahams S, Goldstein LH, Al-Chalabi A, et al. Relation between cognitive 
dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol 
Neurosurg Psychiatry 1997:62;464–72. 
43  Woolley SC, Moore DH, Katz JS. Insight in ALS: awareness of behavioral 
change in patients with and without FTD. Amyotroph Lateral Scler 
2010:11;52–6. 
44  Wicks P, Abrahams S, Masi D, et al. Prevalence of depression in a 12‐month 
consecutive sample of patients with ALS. Eur J Neurol 2007:14;993–1001. 
DAS Dimensional Apathy Scale (Informant/Carer) PN: 
 
 
Relationship to patient………………………………………… 
Choose the answer on what you have observed the person has been feeling, 
behaving or thinking, based on the rate of occurrence in the last month: 
(Circle the statement that applies) 
 
1. S/he needs a bit of 
encouragement to get things 
started 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
2. S/he contacts his/her friends  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
3. S/he expresses his/her 
emotions 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
4. S/he thinks of new things to do 
during the day  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
5. S/he is concerned about how 
his/her family feel  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
6. S/he stares in to space 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
7. Before s/he does something 
s/he thinks about how others 
would feel about it   
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
8. S/he plans his/her days 
activities in advance  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
9. When s/he receives bad news 
s/he feels bad about it 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
10. S/he is able to focus on a 
task until it is finished 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
11. S/he lacks motivation  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
12. S/he struggles to empathise 
with other people 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
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13. S/he sets goals for 
him/herself   
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
14. S/he tries new things   
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
15. S/he is unconcerned about 
how others feel about his/her 
behaviour  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
16. S/he acts on things s/he has 
thought about during the day   
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
17. When doing a demanding 
task, s/he has difficulty working 
out what s/he has to do 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
18. S/he keeps him/herself busy  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
 
 
 
 
19. S/he gets easily confused 
when doing several things at 
once 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
20. S/he becomes emotional 
easily when watching something 
happy or sad on TV   
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
21. S/he finds it difficult to keep 
his/her mind on things 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
22. S/he is spontaneous   
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
23. S/he is easily distracted 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
 
24. S/he is indifferent to what is 
going on around him/her  
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
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INFORMANT/CARER- DAS (DIMENSIONAL 
APATHY SCALE)  
 
Scoring Instructions 
Using the scoring instructions below, sum the total scores for each 
subscale. 
 
Scoring Instructions 
Positive Item Scoring + Negative Item Scoring 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
0 
1 
2 
3 
 Almost always 
 Often 
 Occasionally 
 Hardly Ever 
3 
2 
1 
0 
 
Scoring Sheet 
Executive Subscale 
 
Item Score 
1  
6  
10+  
11  
17  
19  
21  
23  
 
Total: 
 
 
Emotional Subscale 
 
Item Score 
3+  
5+  
7+  
9+  
12  
15  
20+  
24  
 
Total: 
  Behaviour/Cognitive  
Initiation Subscale 
Item Score 
2+  
4+  
8+  
13+  
14+  
16+  
18+  
22+  
 
Total: 
 
 
 
